Annual report pursuant to Section 13 and 15(d)

STOCK BASED COMPENSATION (Tables)

v3.24.0.1
STOCK BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award  
Schedule of option activity

The option activity of the Plans for the year ended December 31, 2023, is as follows (shares in thousands):

    

    

Weighted-Average 

 

Weighted-Average 

Remaining 

 

Aggregate

Number of 

Exercise Price 

Contractual Term 

 

Intrinsic Value

    

Shares

    

per Share

    

(in years)

 

(in thousands)

Outstanding at January 1, 2023

8,423

$

1.83

6.02

922

Granted

 

$

 

Exercised

 

(1,006)

$

1.20

941

Forfeited/expired

 

(1,253)

$

2.32

36

Outstanding as of December 31, 2023

 

6,164

$

1.83

4.97

140

Options vested as of December 31, 2023

 

5,793

$

1.85

4.87

140

Options vested or expected to vest as of December 31, 2023

 

6,162

$

1.83

4.97

140

Schedule of RSU activity under the Plan

The activity for stock subject to vesting under the Plans for the year ended December 31, 2023 is as follows (shares in thousands):

Shares Subject 

    

Weighted-Average

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2023

102

 

$ 8.78

Cancelled/Forfeited

 

$ 8.78

Vested

 

(96)

$ 8.78

Balance of unvested shares as of December 31, 2023

 

6

 

$ 8.78

Schedule of RSU activity

RSU activity under the 2020 Plan for the year ended December 31, 2023 is as follows (shares in thousands):

Shares Subject 

    

Weighted-Average

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2023

22,145

$ 4.15

Granted

10,800

$ 1.76

Vested

(5,803)

$ 4.94

Cancelled/Forfeited

(4,087)

$ 4.05

Balance of unvested shares as of December 31, 2023

23,055

$ 2.84

Schedule of stock-based compensation expense

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the consolidated statements of operations as follows (in thousands):

Years Ended December 31, 

2023

    

2022

    

2021

Research and development(1)

$

14,877

$

24,394

$

11,446

General and administrative expense

 

13,486

 

16,748

 

10,939

Sales and marketing expense

 

2,552

 

5,386

 

4,593

Cost of sales

 

2,262

 

2,257

 

1,800

Total stock-based compensation expense

$

33,177

$

48,785

$

28,778

(1) Includes $7.3 million of stock-based compensation expense during the year ended December 31, 2022, incurred in connection with the 2022 Initiative described in Note 24. Restructuring Charges.

Assumed Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award  
Schedule of assumptions using Black-Scholes option-pricing model

As of November 12, 2021

Risk‑free interest rate

0.5% – 0.8

%

Expected volatility

57.2% – 59.4

%

Expected life (in years)

1.0 – 2.8

Expected dividend yield

Fair value of Common Stock

$

8.61

Market Based Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award  
Schedule of assumptions using Black-Scholes option-pricing model

October 2021

Awards

Risk-free interest rate

1.3

%

Expected dividend yield

%

Remaining performance period (in years)

7.0

Expected volatility

55.0

%

Estimated grant date fair value (per share)

$

0.98 – 4.95

Target performance (number of shares)

9,070,269